Project dates:
Commenced: 2021
Completion Due: 2030
There are 211,000 men in Australia currently living with prostate cancer. Prostate cancer is highly treatable with great survival rates leading to an increase of patients with ongoing follow-up care requirements. Research shows a that a shared-care model is feasible in other cancers, such as breast cancer and lymphoma. A pilot trial, ProCare in 2017 suggested no difference in the adherence to testing recommendations and men involved in the study significantly more likely to prefer a shared-care model to hospital follow-up. MOSES is a significantly larger 4-year clinical trial investigating a share-care model in prostate cancer survivors across multiple sites.
Goal
The MOSES trial is expected to include approximately 490 participants across 6 acute cancer centres and involve 900 General Practitioners in Queensland, South Australia, and Victoria over a four-year period.
Aims
To examine the feasibility of a shared-care system in the follow-up of patients treated for prostate cancer across multiple sites nationally.
To expand on the 2017 ProCare pilot trial and provide evidence for practice change.
Project partners:
Prostate Cancer Foundation of Australia (PCFA) Prostate Cancer Specialist Nurses
Australia and New Zealand Clinical Trials Registry: ACTRN12621001552875
Funding / Grants
- MRFF Primary Health Care Research Initiative
Chief Investigators
Team
Other Team Members
Other Chief Investigators:
Dr Ian Vela Dr Nicolas Hart Lee Jones Professor Jeffrey Dunn Professor Jon Emery Professor Bogda Koczwara Associate Professor Louisa Gordon Professor Michael JeffordResearch Collaborators:
Dr Ian Vela Lee Jones Professor Jeffrey Dunn Professor Jon Emery Associate Professor Louisa Gordon Professor Michael Jefford Professor Ian Davis Professor Shomik Sengupta Dr Carolyn Ee Professor Elizabeth Halcomb Associate Professor Joel Rhee Ms Sally Sara Professor Karla Hemming Associate Professor David Pryor Associate Professor Larisa Haupt Associate Professor Kim Alexander Mr Max Shub Ms Abby RaupachPartners
Other Partners
Flinders University, University of Melbourne, Prostate Cancer Foundation of Australia, The Council of the Queensland Institute of Medical Research, Peter MacCallum Cancer Centre
